P. P. Toth

Endocrinology, Diabetes and Metabolism · 2012

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom P. P. Toth trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. B. J. Gersh
  2. J. Liao

Who trusts P. P. Toth overall

  1. I. Graham
  2. V. Basevi
  3. R. Nelson
  4. T. Ivanova
  5. Børge G. Nordestgaard
  6. Joshua A. Beckman
  7. S. Tsimikas
  8. Peter Libby
  9. Massimo F. Piepoli
  10. Improve-It Investigators

Papers from P. P. Toth's perspective

Ordered by how strongly the researchers P. P. Toth trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
  2. Characteristics of patients with uncontrolled hypertension in the United States. (New England Journal of Medicine)
  3. Myocardial Reperfusion Injury (Journal of Thrombosis and Thrombolysis)
  4. Evolving therapies for myocardial ischemia/reperfusion injury. (Journal of the American College of Cardiology)
  5. The safety of statins in clinical practice. (The Lancet)
  6. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. (New England Journal of Medicine)
  7. The third universal definition of myocardial infarction
  8. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (The Lancet)
  9. Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study (Circulation)
  10. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. (The Lancet)

Their papers